Mineralys Therapeutics In... (MLYS)
13.72
0.19 (1.40%)
At close: Apr 24, 2025, 1:17 PM
Mineralys Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 |
| -177.81M | -153.25M | -119.67M | -90.8M | -71.9M | -56.58M | -40.5M | -34.84M | -29.8M | -27.81M | -21.13M | -14.65M | -7.08M | |
| 43K | 28K | 17K | 8K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
| 11.34M | 9.66M | 5.23M | 6.5M | 5.06M | 3.82M | 2.44M | 1.19M | 455K | 253K | 61K | 35K | 16K | |
| -20.01M | -4.19M | 23.46M | 5.27M | -7.47M | -4.41M | -8.78M | -261K | -199.89K | 721.26K | 984.26K | 265.00 | 157.00 | |
| 22.03M | 21.3M | -4.31M | -6.31M | -6.87M | -5.21M | -3.49M | -1.5M | -647.1K | -235.08K | 3.92K | 2.88K | 2.02K | |
| n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
| -19.71M | -3.98M | 23.64M | 5.27M | -7.47M | -4.41M | -8.78M | -261K | 772K | 3.87M | 4.13M | 3.15M | 2.18M | |
| -166.31M | -128.45M | -97.3M | -87.54M | -81.17M | -62.38M | -50.34M | -35.42M | -29.22M | -23.93M | -16.94M | -11.47M | -4.89M | |
| -96K | -96K | -59K | -59K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
| n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
| -373.44M | -382.6M | -379.74M | -308.61M | -347.97M | -274.88M | -290.65M | -234.51M | -71.76M | -71.76M | n/a | n/a | n/a | |
| 488.5M | 406M | 327.5M | 232.5M | 187.5M | 172.5M | 112.5M | 72.5M | 50M | n/a | n/a | n/a | n/a | |
| -55.89K | -63.98K | -59.98K | -76.11K | -20.22K | 49.99M | 49.91M | 49.93M | 49.93M | -71.76K | n/a | n/a | n/a | |
| 114.96M | 23.3M | -52.3M | -76.17M | -160.47M | -102.38M | -178.15M | -162.01M | -21.76M | -71.76M | n/a | n/a | n/a | |
| n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
| 138K | 202.58K | 64.58K | 64.58K | 64.58K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
| n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
| 83K | 67K | 252K | 344K | 258K | -884K | -1.07M | -1.07M | -1.07M | n/a | n/a | n/a | n/a | |
| 116.14M | 116.13M | 116.31M | 115.88M | 203.25M | 202.11M | 201.36M | 319.59M | 128.02M | 129.09M | 129.65M | 12M | n/a | |
| 64.79M | 10.97M | -33.28M | -47.83M | -38.4M | 37.34M | -27.12M | 122.17M | 77.04M | 33.4M | 112.71M | 529K | -4.89M | |
| -166.41M | -128.55M | -97.36M | -87.6M | -81.17M | -62.38M | -50.34M | -35.42M | -29.22M | -23.93M | -16.94M | -11.47M | -4.89M |